Scientists track blood signal in families destined for dementia
NCT ID NCT04516499
Summary
This study aims to track a specific protein in the blood (neurofilament light chain) over three years in people who carry a genetic risk for frontotemporal dementia (FTD). It involves 342 participants who will have blood drawn remotely four times a year. The goal is to see if this protein can be used as a reliable measure in future trials testing drugs to prevent or delay the disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FRONTOTEMPORAL DEMENTIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Columbia University
New York, New York, 10032, United States
-
Johns Hopkins University School of Medicine
Baltimore, Maryland, 21287, United States
-
Massachusetts General Hospital
Charlestown, Massachusetts, 02129, United States
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
-
Mayo Clinic Florida
Jacksonville, Florida, 32224, United States
-
University of California, San Francisco
San Francisco, California, 94158, United States
-
University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
-
Washington University in St. Louis
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.